Skip to main content
Sign in
Menu
Membership
Events
Knowledge Center
About
Register
Search
Sign In
Sign In
Register
Subscribe
Premium
Alternative Insight and Premium Journalism
Latest Articles
For Members Only
It Was a Tough Year to Be a Tiger
Stephen Taub
January 11, 2023
For Members Only
What Drove Third Point’s Disastrous Year
Stephen Taub
January 10, 2023
For Members Only
Glenview Posts Mixed Results in 2022
Stephen Taub
January 9, 2023
For Members Only
Citadel Posts Its Biggest Gain in Over a Decade
Stephen Taub
January 6, 2023
For Members Only
Bridgewater Rebounds in December
Stephen Taub
January 4, 2023
For Members Only
Hedge Fund Favorites Limp to the Finish Line
Stephen Taub
January 3, 2023
For Members Only
Greenlight Ends 2022 on a High Note
Stephen Taub
January 3, 2023
For Members Only
Greenlight Ends 2022 on a High Note
Stephen Taub
January 3, 2023
For Members Only
Elon Musk’s Twitter Takeover Has Turned Tesla Into 2022’s Most Profitable Short
Michelle Celarier
December 21, 2022
For Members Only
Elon Musk’s Twitter Takeover Has Turned Tesla Into 2022’s Most Profitable Short
Michelle Celarier
December 21, 2022
For Members Only
Biopharma Funds Are Still Embracing VC
Stephen Taub
December 21, 2022
For Members Only
Tech Funds Shun VC Investments
Stephen Taub
December 20, 2022
For Members Only
JW Asset Management Has a Sobering Year
Stephen Taub
December 19, 2022
For Members Only
It’s Been a Bad Year for IPOs — But Hedge Funds Are Betting on These New Offerings
Stephen Taub
December 16, 2022
For Members Only
Franklin Templeton Strikes Back at Saba in Closed-End Battle
Richard Teitelbaum
December 15, 2022
For Members Only
The Prognosis Brightens for Biopharma Funds
Stephen Taub
December 14, 2022
For Members Only
The Hedge Funds Behind the Coupa Deal
Stephen Taub
December 13, 2022
For Members Only
Light Street’s 2022 Keeps Getting Worse
Stephen Taub
December 12, 2022
More Articles